Babajide Kayode
Research Subjects
Babajide Kayode has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adesegun Adeyemo
Lagos State University
2 shared publications - Olasunkanmi Kayode Awote
Molecular Biophysics and Structural Biology Group, Department of Biochemistry, University of Johannesburg, Auckland Park, Johannesburg 2006, Gauteng, South Africa
2 shared publications - Bisola Omotayo
Lagos State University
1 shared publication - Blessing Ogunyinka
Lagos State University, Nigeria
1 shared publication - Dasola Akorede
Eko UniMed
1 shared publication - Ibrahim Adenekan
University of Louisiana at Lafayette, LA, United States of America
1 shared publication
Latest Publications
- Open Access
- 19 December 2025
- Published by ISRES Publishing in Zeugma Biological Science
- Vol. 7 (1) , 28-42
In Silico Profiling of Pharmacokinetic Properties and Inhibitory Potentials of Chromolaena odorata aqueous leaf extract against Type-2 Diabetes Protein Targets, Neprilysin and Alpha Amylase
Chronic type 2 diabetes interferes with the body's ability to use insulin as intended. Two protein targets, neprilysin and alpha amylase have been reported to contribute to the emergence of type 2 diabetes. Type 2 diabetes medications are ineffective and have unfavorable side effects. The objective of this study was to discover novel chemical agents of Chromolaena odorata aqueous leaf extract that can precisely inhibit the proteins, neprilysin and alpha amylase in type 2 diabetes to restrict the proteins' actions and so covertly induce anti-diabetic effects. Using GC-MS analysis, the phytoconstituents of Chromolaena odorata's aqueous leaf extract were identified. Ten (10) of the twenty-one (21) identified compounds complied with Lipinski rule of five. Swiss-ADME (Absorption, Distribution, Metabolism & Excretion) was used to analyze the pharmacokinetic properties of the compounds that did not violate the Lipinski rule. ADME analysis revealed that the selected compounds displayed suitable pharmacokinetic properties. Molecular docking was employed using PyRx and Biovia Discovery Studio software to predict potential selected bioactive antagonists and non-covalent interactions between the selected ligands, standard drugs and the target proteins. The findings from this study revealed that the identified ligand (carbamic acid) had the highest binding affinity against the target protein neprilysin and alpha amylase when compared to the standard drug, and it also has the potential to advance into pre-clinical and clinical research for future development as an antidiabetic medication.
- 19 December 2025
- Published by ISRES Publishing in Zeugma Biological Science
- Vol. 7 (1) , 28-42
Open AccessIn Silico Profiling of Pharmacokinetic Properties and Inhibitory Potentials of Chromolaena odorata aqueous leaf extract against Type-2 Diabetes Protein Targets, Neprilysin and Alpha Amylase
Chronic type 2 diabetes interferes with the body's ability to use insulin as intended. Two protein targets, neprilysin and alpha amylase have been reported to contribute to the emergence of type 2 diabetes. Type 2 diabetes medications are ineffective and have unfavorable side effects. The objective of this study was to discover novel chemical agents of Chromolaena odorata aqueous leaf extract that can precisely inhibit the proteins, neprilysin and alpha amylase in type 2 diabetes to restrict the proteins' actions and so covertly induce anti-diabetic effects. Using GC-MS analysis, the phytoconstituents of Chromolaena odorata's aqueous leaf extract were identified. Ten (10) of the twenty-one (21) identified compounds complied with Lipinski rule of five. Swiss-ADME (Absorption, Distribution, Metabolism & Excretion) was used to analyze the pharmacokinetic properties of the compounds that did not violate the Lipinski rule. ADME analysis revealed that the selected compounds displayed suitable pharmacokinetic properties. Molecular docking was employed using PyRx and Biovia Discovery Studio software to predict potential selected bioactive antagonists and non-covalent interactions between the selected ligands, standard drugs and the target proteins. The findings from this study revealed that the identified ligand (carbamic acid) had the highest binding affinity against the target protein neprilysin and alpha amylase when compared to the standard drug, and it also has the potential to advance into pre-clinical and clinical research for future development as an antidiabetic medication.
- Open Access
- 29 March 2024
- Published by ISRES Publishing in Zeugma Biological Science
- Vol. 6 (2) , 41-71
Ameliorative Potential of the Polyphenolic Compounds in Cucumis sativus (Linn.) Fruit Pulp Extract on Streptozotocin-induced Diabetes in Male Wistar Rats
Diabetes mellitus continues to be a major global public health concern, underscoring the urgent need for continuous exploration of locally available medicinal plants and functional foods that are affordable, accessible, and capable of supporting effective management and improved health outcomes. This study investigated the effect of Cucumis sativus pulp extract (CSPE) on selected oxidative stress and diabetes-related biochemical indices. A total of 24 male Wistar rats were divided into 4 groups (n=6), including control, diabetic-untreated, and diabetic-treated groups (with CSPE or glibenclamide). Oxidative stress (hydrogen peroxide [H2O2], nitric oxide [NO], malondialdehyde [MDA], glutathione [GSH]); lipid profile (total cholesterol [TC], triglyceride [TRIG], high-density [HDL-Chol, low-density [LDL-Chol], and very-low-density [VLDL-Chol] lipoprotein cholesterol; liver antioxidant (superoxide dismutase [SOD], catalase [CAT]); and liver function (alanine [ALT], and aspartate [AST] aminotransferase) enzymes were evaluated using standard biochemical kits and procedures. PyRx and Biovia Discovery Studio were used for molecular docking studies while swissADME and ProTox were used to predict the ADME/T properties. Results showed that treatment with CSPE had a significant (p
- 29 March 2024
- Published by ISRES Publishing in Zeugma Biological Science
- Vol. 6 (2) , 41-71
Open AccessAmeliorative Potential of the Polyphenolic Compounds in Cucumis sativus (Linn.) Fruit Pulp Extract on Streptozotocin-induced Diabetes in Male Wistar Rats
Diabetes mellitus continues to be a major global public health concern, underscoring the urgent need for continuous exploration of locally available medicinal plants and functional foods that are affordable, accessible, and capable of supporting effective management and improved health outcomes. This study investigated the effect of Cucumis sativus pulp extract (CSPE) on selected oxidative stress and diabetes-related biochemical indices. A total of 24 male Wistar rats were divided into 4 groups (n=6), including control, diabetic-untreated, and diabetic-treated groups (with CSPE or glibenclamide). Oxidative stress (hydrogen peroxide [H2O2], nitric oxide [NO], malondialdehyde [MDA], glutathione [GSH]); lipid profile (total cholesterol [TC], triglyceride [TRIG], high-density [HDL-Chol, low-density [LDL-Chol], and very-low-density [VLDL-Chol] lipoprotein cholesterol; liver antioxidant (superoxide dismutase [SOD], catalase [CAT]); and liver function (alanine [ALT], and aspartate [AST] aminotransferase) enzymes were evaluated using standard biochemical kits and procedures. PyRx and Biovia Discovery Studio were used for molecular docking studies while swissADME and ProTox were used to predict the ADME/T properties. Results showed that treatment with CSPE had a significant (p